The short answer: Stage 2 cervical cancer (bachedani ke muh ka cancer, बच्चेदानी के मुँह का कैंसर) means the cancer has grown beyond the cervix into the upper part of the vagina or into the tissue beside the cervix, but has not reached the pelvic wall or the lower part of the vagina. Many women at this stage are treated with the aim of cure. For most stage 2 cancers, and especially stage 2B, the usual main treatment is chemoradiation: radiotherapy (sikai) given with weekly chemotherapy, followed by internal radiotherapy (brachytherapy). An operation (radical hysterectomy) is considered only for selected small stage 2A cancers. The right choice depends on the exact sub-stage, the tumour size, MRI and PET-CT findings, and your general health.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
What does this stage mean?
Stage 2 cervical cancer has spread beyond the cervix but not to the pelvic side wall or the lower third of the vagina. It is divided into:
- Stage 2A: the cancer has reached the upper two-thirds of the vagina, but not the tissue beside the cervix. Stage 2A1 is under 4 cm; stage 2A2 is 4 cm or more.
- Stage 2B: the cancer has spread into the tissue beside the cervix (the parametrium), but not as far as the pelvic wall.
The stage is set by examination, MRI and often PET-CT. If scans show cancer in the lymph nodes, the stage becomes 3C (in the current 2018 FIGO system), which changes the treatment plan.
For broader information, see our guide to cervical cancer diagnosis and care and our page on radiation therapy in cervical cancer care.
Recommended treatment pathway
Stage 2B: chemoradiation is the standard treatment. This means external radiotherapy, usually about 25 sessions over about 5 weeks, with chemotherapy (usually cisplatin once a week) to make the radiotherapy work better, followed by brachytherapy, in which the radiation source is placed close to the tumour. Brachytherapy should ideally be planned with imaging (image-guided brachytherapy) and is an essential part of treatment, not an optional extra.
Stage 2A: for a selected small stage 2A1 cancer, a radical hysterectomy may be considered. For most others, chemoradiation is preferred. One reason is that if the report after surgery shows risk features, radiotherapy is often needed afterwards as well, and having both treatments causes more long-term side effects.
Surgery is not routinely better than chemoradiation at this stage. If a radical hysterectomy is chosen, open surgery is the standard for most women, because a large 2018 study (the LACC trial) found lower survival with keyhole and robotic radical hysterectomy. Some selected women may also be offered a short course of chemotherapy before chemoradiation (induction chemotherapy), as explained on our stage 3 cervical cancer treatment page.
Adjuvant therapy
Adjuvant treatment means treatment given after surgery. If a radical hysterectomy has been done for a selected stage 2A cancer, radiotherapy or chemoradiation may be advised afterwards when the final report shows risk features, such as cancer in the lymph nodes, at the cut edge or in the tissue beside the cervix. For women treated with chemoradiation, no routine operation is needed afterwards; the response is checked with examination and scans after an interval.
Outlook
Many women with stage 2 cervical cancer are treated with the aim of cure. Published series report 5-year survival of approximately 65-75% with optimal chemoradiation, and up to 80% in carefully selected surgical candidates. Women chosen for surgery usually have smaller, earlier tumours, so these figures cannot be compared directly and do not mean surgery is better. Your own outlook depends on the sub-stage, tumour size, lymph nodes and whether the full treatment, including brachytherapy, is completed.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is stage 2 cervical cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
Chemoradiation is mostly given as outpatient treatment: about 25 radiotherapy sessions over about 5 weeks, plus brachytherapy, which may need anaesthesia or sedation and sometimes a short admission, depending on the technique. If a radical hysterectomy is chosen for a selected stage 2A cancer, the stay is often about 6–8 days after open surgery.
What is the likely outcome?
5-year survival approximately 65-75% with optimal chemoradiation; up to 80% in carefully selected surgical candidates. Women chosen for surgery usually have smaller tumours, so this does not mean surgery is better. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is stage 2 cervical cancer curable?
Many women with stage 2 cervical cancer are treated with the aim of cure, usually with chemoradiation and brachytherapy. The chance depends on the sub-stage (2A or 2B), the tumour size, the lymph nodes and your general health, and on completing the full course of treatment.
Is surgery better than chemoradiation for stage 2?
Not routinely. For stage 2B, chemoradiation is the standard treatment. For a selected small stage 2A cancer, surgery may be an option; your team will compare the two for your situation, including the long-term side effects of each.
Is fertility preservation possible?
Keeping the womb is not usually possible at this stage, and pelvic radiotherapy usually stops the ovaries working, causing early menopause. Before treatment starts, ask whether egg or embryo freezing (often about 2 weeks) or moving the ovaries out of the radiation area is possible for you; these are not suitable for everyone and should not delay treatment unduly.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.